Reports

Crown Castle reported Q4 2024 revenue of $1.65 billion, slightly declining from the previous year. The company posted a net loss of $4.77 billion due to a $4.96 billion goodwill impairment charge related to the Fiber segment. Tower site rental revenues remained steady, while the company finalized the sale of its Fiber segment for $8.5 billion, positioning itself as a pure-play tower company.

• Total revenue declined to $1.65 billion, down from $1.67 billion in Q4 2023.
• Net loss of $4.77 billion due to a $4.96 billion goodwill impairment charge.

Wheaton Precious Metals achieved record revenue of $381 million and adjusted net earnings of $199 million in Q4 2024. The company's operating cash flow reached $319 million, reflecting strong performance across its mining assets. Despite a decline in net earnings due to impairment charges, Wheaton's balance sheet remained robust, with $818 million in cash and no debt.

• Revenue reached a record $381 million, up 21.4% from Q4 2023.
• Adjusted net earnings increased to $199 million, a 20.9% year-over-year rise.

Ulta Beauty reported net sales of $3.49 billion, reflecting a 1.9% YoY decline due to the prior year's extra week. Comparable sales increased by 1.5%, supported by higher average ticket size. Net income remained stable, while diluted EPS increased to $8.46. The company continued expansion, adding 8 net new stores during the quarter.

• Net sales reached $3.49 billion, down 1.9% YoY due to the prior year's extra week.
• Comparable sales increased 1.5%, driven by a 3.0% rise in average ticket size.

DocuSign achieved a 9% YoY revenue increase, reaching $776.3 million. Net income and free cash flow saw substantial growth. The company also expanded its AI-powered Intelligent Agreement Management platform globally.

• Total revenue increased by 9% YoY to $776.3 million.
• Net income rose significantly to $83.5 million.

Dollar General's Q4 2024 revenue grew by 4.5% to $10.3 billion, driven by new store openings and modest same-store sales growth. However, operating profit dropped 49.2% due to store portfolio review charges, leading to a 52.5% decline in EPS. The company remains optimistic about future performance and is focusing on long-term growth strategies.

• Revenue increased by 4.5% to $10.3 billion.
• Net income fell 52.4% to $191.2 million.

Rubrik reported total revenue of $258.1 million, reflecting a 47% year-over-year increase. Subscription ARR grew 39% to $1.09 billion, demonstrating strong demand for the company's cybersecurity solutions. While the company continued to operate at a loss, non-GAAP EPS improved from the prior year. Free cash flow turned positive at $75.2 million, reflecting improved operational efficiency.

• Total revenue increased 47% YoY to $258.1 million.
• Subscription ARR grew 39% YoY to $1.09 billion.

Futu achieved significant revenue growth of 86.8% YoY, driven by a surge in trading volume and strong performance across markets. Net income more than doubled, reflecting operational efficiency and increased client activity. Non-GAAP adjusted net income also saw substantial gains.

• Total revenue increased by 86.8% YoY to $570.6 million.
• Net income rose by 113.3% YoY to $240.7 million.

Semtech posted revenue of $251.0 million in Q4 FY25, reflecting a 30.1% YoY increase. GAAP operating margin improved to 8.5%, while non-GAAP operating margin reached 19.9%. Net income was $39.1 million, and free cash flow came in at $30.9 million. The company highlighted margin expansion as a key focus for FY26.

• Total revenue increased 30.1% YoY to $251.0 million.
• GAAP gross margin reached 52.0%, while non-GAAP gross margin was 53.2%.

EverCommerce posted revenue of $175.0 million, up 3.3% year-over-year. Subscription and transaction fee revenue grew 4.2%, reaching $139.0 million. The company reported a net loss of $12.2 million but saw adjusted EBITDA rise to $50.4 million, demonstrating improved profitability. EverCommerce also repurchased 0.6 million shares during the quarter.

• Total revenue increased 3.3% YoY to $175.0 million.
• Subscription and transaction fee revenue grew 4.2% to $139.0 million.

PagerDuty reported total revenue of $121.4 million, up 9.3% year-over-year. While the company remained unprofitable on a GAAP basis, non-GAAP operating income improved significantly. Free cash flow reached $28.6 million, reflecting strong financial management. The company also announced a $150 million share repurchase program.

• Total revenue increased 9.3% YoY to $121.4 million.
• Non-GAAP EPS improved to $0.22, up from $0.17 in Q4 FY24.

Weibo's Q4 2024 revenue declined by 1% year-over-year to $456.8 million, with a decrease in advertising revenue but strong growth in value-added services. Net income was significantly lower compared to the previous year, though non-GAAP earnings showed improvement. The company's operational efficiency remained strong, maintaining a 26% operating margin.

• Total revenue was $456.8 million, down 1% YoY.
• Net income fell to $8.9 million from $83.2 million in Q4 2023.

G-III Apparel's Q4 2025 revenue increased by 9.8% to $839.5 million, reflecting strong demand and expansion efforts. Net income grew to $48.8 million, with diluted EPS rising 75.4% to $1.07. Non-GAAP EPS reached $1.27, driven by margin expansion and operational efficiency. Inventory management improved, with an 8% reduction in stock levels.

• Revenue increased 9.8% to $839.5 million.
• Net income rose to $48.8 million, up from $28.9 million last year.

Adecoagro reported a 7.9% year-over-year decrease in revenue for Q4 2024, reaching $368.38 million. Adjusted net income turned positive at $45.90 million, compared to a loss of $16.40 million in the previous year. Adjusted EBITDA increased by 7.8% to $103.25 million, driven by record production in the Sugar, Ethanol & Energy segment, though results were offset by lower sales in Crops and Rice segments.

• Revenue declined 7.9% year-over-year to $368.38 million due to lower sugar and ethanol prices.
• Adjusted net income turned positive at $45.90 million, a major improvement from last year’s loss.

D-Wave's Q4 2024 revenue declined by 21% to $2.3 million, primarily due to lower professional services revenue. However, bookings surged 502% year-over-year to a record $18.3 million. Despite a 25% drop in gross profit, the company maintained a 63.8% gross margin. Net loss widened to $86.1 million due to a non-cash remeasurement charge related to warrant liabilities.

• Revenue decreased by 21% to $2.3 million.
• Bookings surged 502% to $18.3 million.

Karat Packaging posted net sales of $101.6 million, a 6.3% increase year-over-year. Adjusted EBITDA rose to $11.3 million, representing an adjusted EBITDA margin of 11.1%. Net income improved significantly by 40.3% to $5.9 million. The company continues to expand its eco-friendly product lines, which contributed 35% of total sales.

• Total revenue increased 6.3% YoY to $101.6 million.
• Adjusted EBITDA rose to $11.3 million, up from $8.6 million in Q4 2023.

Pharming's Q4 2024 revenue increased by 14% year-over-year to $92.7 million, with RUCONEST® revenue rising 9% and Joenja® revenue surging 66%. Operating profit grew significantly, reflecting strong product performance and increased patient enrollments. The company continued investments in research and acquisitions to expand its rare disease portfolio.

• Total revenue increased 14% YoY to $92.7 million.
• RUCONEST® revenue rose 9% to $79.6 million, while Joenja® revenue surged 66% to $13.1 million.

Build-A-Bear's Q4 2024 revenue grew by 0.8% to $150.4 million, with net income reaching $21.7 million. Adjusted EPS increased by 18.7% to $1.59. Despite a decline in e-commerce demand, commercial and international franchise revenues grew by 20.5%. The company also announced a 10% dividend increase.

• Total revenue increased 0.8% to $150.4 million.
• Net income reached $21.7 million, representing 14.4% of total revenue.

Xponential Fitness saw a 7% decrease in revenue, reporting $83.2 million for Q4 2024. The company posted a net loss of $62.5 million, compared to a loss of $12.3 million in Q4 2023. Adjusted EBITDA improved to $30.8 million. North America system-wide sales increased by 21%, while same-store sales grew by 5%.

• Revenue declined 7% to $83.2 million due to lower equipment, merchandise, and other service revenues.
• North America system-wide sales increased 21% to $464.7 million.

Akebia's Q4 2024 revenue declined 17.2% to $46.5 million due to lower Auryxia sales and reduced collaboration revenue. Net loss widened to $22.8 million compared to a small profit in Q4 2023. Operating expenses increased, driven by Vafseo's U.S. launch preparations. Cash reserves improved to $51.9 million, with further funding secured post-year-end.

• Total revenue declined 17.2% to $46.5 million.
• Net loss widened to $22.8 million from a $0.6 million profit last year.

VAALCO Energy, Inc. announced its fourth quarter and record full year 2024 financial and operating results. The company reported a net income of $11.7 million and Adjusted EBITDAX of $76.2 million for Q4 2024. Full year highlights included a record Adjusted EBITDAX of $303.0 million, a 7% year-over-year production growth, and a 57% increase in year-end 2024 SEC proved reserves to 45.0 MMBOE.

• Net income for Q4 2024 was $11.7 million ($0.11 per diluted share), with Adjusted EBITDAX of $76.2 million.
• Produced 20,775 net revenue interest (NRI) BOEPD and sold 20,352 NRI BOEPD in Q4 2024.

Acacia Research Corporation reported Q4 2024 revenue of $48.8 million, driven by acquisitions in the energy and manufacturing sectors. Despite this, the company posted a net loss of $13.4 million. Adjusted EBITDA was positive at $4.9 million, reflecting operational improvements and cost efficiencies.

• Total revenue for Q4 2024 was $48.8 million, supported by acquisitions in the energy and manufacturing segments.
• Net loss for the quarter was $13.4 million, with a GAAP EPS of $(0.14).

Ballard Power Systems reported Q4 2024 revenue of $24.5 million, a 48% year-over-year decline. The company faced negative gross margins of (13%) but showed improvement compared to Q4 2023. Net loss for the quarter was $46.5 million, with an EPS of ($0.16). Despite these challenges, Ballard secured a record year-ending order backlog of $173.5 million, driven by strong order intake.

• Total revenue for Q4 2024 was $24.5 million, down 48% year-over-year.
• Gross margin improved to (13%) from (22%) in Q4 2023 due to reduced impairments and warranty expirations.

Allogene Therapeutics reported a Q4 2024 net loss of $59.9 million, with no revenue recognized for the quarter. The company ended the year with $373.1 million in cash and investments, projecting its cash runway into the second half of 2026. R&D expenses totaled $45.0 million, including $5.6 million in stock-based compensation, while general and administrative expenses were $15.5 million, including $7.3 million in stock-based compensation.

• Net loss for Q4 2024 was $59.9 million, or $0.28 per share.
• Cash, cash equivalents, and investments totaled $373.1 million at year-end.

REGENXBIO reported Q4 2024 revenue of $21.2 million, a slight decrease from the previous year, primarily due to lower royalty revenues. Net loss for the quarter improved to $51.2 million compared to $62.9 million in Q4 2023. The company ended the year with $244.9 million in cash and expects its cash runway to extend into the second half of 2026. R&D expenses were $50.4 million, reflecting continued investment in gene therapy programs.

• Q4 2024 revenue was $21.2 million, down from $22.2 million in Q4 2023.
• Net loss improved to $51.2 million, compared to $62.9 million in the prior year.

Turtle Beach reported Q4 2024 revenue of $146.1 million, a 47% increase from the prior year. Net income more than doubled to $20.1 million, while Adjusted EBITDA grew 156% to $35.7 million. Gross margin expanded by 500 basis points to 37.0%, driven by product innovation and operational efficiencies. The company continues to capitalize on strong gaming accessory demand and expects further growth in 2025.

• Record quarterly revenue of $146.1 million, up 47% year-over-year.
• Net income surged to $20.1 million from $8.6 million in the prior year.

Pangaea Logistics Solutions Ltd. delivered solid financial results in Q4 2024, with net income reaching $8.4 million and adjusted net income of $7.6 million. The company achieved a Time Charter Equivalent (TCE) rate of $15,942 per day, outperforming market benchmarks by 48%. Total revenue for the quarter stood at $147.2 million, while adjusted EBITDA grew 18% year-over-year to $23.2 million.

• Net income of $8.4 million and adjusted net income of $7.6 million.
• Time Charter Equivalent (TCE) rate of $15,942 per day, exceeding benchmarks by 48%.

Nyxoah's Q4 2024 revenue reached €1.3 million, with a gross margin of 73%. However, increased research and development expenses contributed to a higher operating loss of €18.3 million. The company is preparing for its U.S. commercial launch in March 2025, following anticipated FDA approval.

• Total revenue was €1.3 million, impacted by deferred revenue recognition.
• Gross margin improved to 73%, up from 60% in Q4 2023.

Zumiez Inc. reported a net income of $14.8 million in Q4 2024, reversing a net loss from the prior year. EPS improved to $0.78, supported by a 5.9% increase in comparable sales. Gross margin expanded by 190 basis points to 36.2%, driven by reduced costs. Total revenue for the quarter reached $279.2 million, reflecting a slight 0.9% decrease due to an extra week in the prior year's quarter.

• Net income of $14.8 million, reversing a net loss of $33.5 million last year.
• EPS improved to $0.78 from a loss of $1.73 in Q4 2023.

Blade's Q4 2024 revenue grew by 14.5% to $54.4 million, driven by strong performance in the Medical segment. Net loss improved by 71.1% to $9.8 million, and Adjusted EBITDA saw a substantial improvement, reaching near break-even at $(0.4) million. Flight profit increased by 39.7%, with a flight margin expansion to 23.2%.

• Revenue increased 14.5% to $54.4 million.
• Net loss improved 71.1% to $(9.8) million.

Vuzix Inc. reported total revenue of $1.3 million in Q4 2024, reflecting an increase driven by higher unit sales of M400 smart glasses. Despite this, the company posted a net loss of $13.7 million, though reduced from the prior year. Operating expenses declined, including research and development, selling and marketing, and general administrative costs, positioning the company for improved financial efficiency.

• Total revenue increased to $1.3 million, up from $1.1 million in Q4 2023.
• Net loss improved to $13.7 million, compared to $19.9 million in Q4 2023.

FiscalNote Holdings, Inc. posted Q4 2024 revenue of $29.5 million, down 14% year-over-year, due to divestitures and discontinued products. However, the company improved its profitability, reporting an adjusted EBITDA of $3.3 million and a net loss reduction to $13.4 million. Gross margin increased significantly to 82%, supported by operational efficiencies and a streamlined business model.

• Total revenue declined 14% to $29.5 million due to divestitures and product discontinuations.
• Net loss improved to $13.4 million from $50.7 million in Q4 2023.

AFC Gamma reported a net loss of $1.0 million for Q4 2024, with an EPS of ($0.05). Despite the loss, the company generated $9.2 million in interest income. Loan commitments remained stable, and AFC maintained a disciplined lending approach in the cannabis sector, focusing on capital preservation and risk-adjusted returns.

• Total revenue for Q4 2024 was $9.2 million from interest income.
• Net loss for the quarter was $1.0 million, with an EPS of ($0.05).

The Joint Corp. posted a 14% revenue increase in Q4 2024, reaching $14.4 million. System-wide sales grew by 9%, while comp sales rose 6%. The company reported net income of $986,000, a significant turnaround from the prior year’s net loss. The business continued to focus on franchising and operational efficiency, leading to improved Adjusted EBITDA of $2.1 million.

• Total revenue increased by 14% to $14.4 million in Q4 2024.
• Net income improved to $986,000 from a loss of $10.2 million in Q4 2023.

PublicSquare reported Q4 2024 revenue of $7.2 million, a 167% year-over-year increase driven by its Financial Technology and Brands segments. Gross margin expanded to 61%, reflecting improved operational efficiency. However, the company recorded a net loss of $20.7 million due to high operating expenses. Cash and cash equivalents rose to $36.3 million, providing financial stability for future growth.

• Revenue surged 167% year-over-year to $7.2 million in Q4 2024.
• Gross margin expanded to 61% from 38% in the prior year.

Perma-Fix faced a challenging Q4 2024, with revenue declining to $14.7 million, driven by lower waste volume and delays in project starts. The company reported a net loss of $3.5 million and an operating loss of $3.6 million. Despite short-term financial pressures, management expects revenue growth in 2025, supported by increased waste processing capacity and new contract wins.

• Revenue for Q4 2024 declined to $14.7 million from $22.7 million in Q4 2023.
• Net loss of $3.5 million compared to a net income of $81,000 in Q4 2023.

Xunlei's Q4 2024 revenue increased 9.3% year-over-year, driven by strong growth in subscription and live-streaming services. However, a decline in cloud computing revenue and an impairment charge to goodwill led to a net loss of $9.9 million. Non-GAAP net income was positive at $11.3 million, highlighting the strength of the core business. The company remains focused on subscription growth and expanding its digital content ecosystem.

• Total revenue increased by 9.3% YoY to $84.3 million.
• Cloud computing revenue declined 25.6% YoY to $22.7 million.

Origin Materials reported Q4 2024 revenue of $9.2 million, primarily from its supply chain activation program, reflecting a decline from the prior year. The company ramped up its CapFormer production with the first PET cap manufacturing line now in commercial production. Net loss widened to $13.5 million due to operating expenses of $16.2 million. The company secured financing to expand manufacturing and maintain a stable cash position of $102.9 million.

• Revenue of $9.2 million, down from $13.1 million in Q4 2023.
• Net loss increased to $13.5 million due to ongoing operational investments.

Seres Therapeutics' Q4 2024 revenue was classified under discontinued operations due to the sale of its VOWST business. The company reported a net loss of $15.7 million, a significant improvement from the $34.7 million loss in Q4 2023. Operating expenses decreased as the company streamlined its focus on SER-155. Cash and cash equivalents stood at $30.8 million, with additional funding expected from Nestlé in mid-2025.

• Net loss improved to $15.7 million from $34.7 million in Q4 2023.
• Cash and cash equivalents stood at $30.8 million as of year-end.

Veritone posted Q4 2024 revenue of $22.4 million, a 17% decline year-over-year, primarily due to lower consumption in its AI software segment. However, the company reported a net income of $31.8 million, benefiting from a gain on discontinued operations. Operating loss remained flat at $19.7 million, reflecting ongoing efficiency measures. Annual recurring revenue declined to $58.8 million, down 27% year-over-year.

• Total revenue declined 17% to $22.4 million due to lower AI software consumption.
• Net income of $31.8 million, driven by a one-time gain from discontinued operations.

Blink Charging's fourth quarter of 2024 saw total revenues decrease to $30.2 million from $42.7 million in the prior year, largely driven by a significant drop in product sales. However, service revenues demonstrated strong growth, increasing by 24% to $9.8 million, and contributed a larger portion of total revenue compared to the previous year. The company reported a net loss of $(73.5) million and an adjusted EBITDA loss of $(10.6) million for the quarter.

• Total revenues for Q4 2024 were $30.2 million, a decrease from $42.7 million in Q4 2023.
• Service revenues grew 24% to $9.8 million in Q4 2024, contributing 33% of total revenue.

Zomedica's Q4 2024 revenue grew to $7.9 million, an 8% increase year-over-year, driven by 109% growth in its Diagnostics segment. The company reported a net loss of $7.2 million, a significant improvement from the $22.4 million net loss in Q4 2023. Gross margin was strong at 70.3%, while non-GAAP adjusted EBITDA loss improved to $5.4 million. Cash and cash equivalents at the end of the quarter stood at $71.4 million, supporting future growth initiatives.

• Q4 2024 revenue reached a record $7.9 million, up 8% year-over-year.
• Diagnostics segment revenue surged 109%, driven by TRUFORMA® adoption.

Skillz faced a challenging fourth quarter with revenue of $20.4 million, down from the prior year. The company reported a net loss of $26.4 million and a negative Adjusted EBITDA of $18.5 million. Paying monthly active users decreased, but the company remains focused on improving financial performance through strategic initiatives.

• Revenue declined to $20.4 million in Q4 2024.
• Net loss widened to $26.4 million.

Cellectis achieved a remarkable revenue increase in Q4 2024, reaching $28.92 million compared to just $0.28 million in the prior year. The company significantly reduced its net loss to $17.13 million from $41.79 million in Q4 2023. Operating losses improved to $21.45 million, supported by a financial gain of $4.77 million. The company ended the quarter with $264 million in cash, ensuring a runway into mid-2027.

• Q4 2024 revenue surged to $28.92 million from $0.28 million in Q4 2023.
• Net loss improved significantly to $17.13 million from $41.79 million in Q4 2023.

Duluth Trading's Q4 2024 revenue decreased by 1.8% year-over-year to $241.3 million, with a decline in retail store sales offsetting a slight increase in direct-to-consumer sales. The company posted a net loss of $5.6 million, driven by lower margins and a $3.0 million software impairment. Adjusted EBITDA was significantly lower than the prior year due to increased discounting and operational inefficiencies.

• Total revenue declined 1.8% YoY to $241.3 million.
• Gross profit margin fell to 44.1%, down from 48.2% in Q4 2023.

Emeren faced revenue declines in Q4 2024 due to project timing delays but maintained a resilient financial position with strong contributions from its high-margin DSA and IPP businesses. The company reported revenue of $34.6 million, a net loss of $11.8 million, and a gross margin of 13.9%. Despite foreign exchange losses impacting profitability, Emeren increased its cash position and remains well-positioned for 2025 growth.

• Q4 2024 revenue declined 23% year-over-year to $34.6 million.
• Net loss widened to $11.8 million due to foreign exchange losses.

Century Casinos' Q4 2024 revenue declined by 4% to $137.8 million, with a net loss of $64.9 million due to a $43.7 million goodwill impairment charge at the Nugget Casino Resort. Adjusted EBITDAR decreased by 17% to $21.1 million. The company attributed weak performance to macroeconomic factors impacting consumer spending but expects improvements in 2025 with the opening of its new Missouri casino.

• Net revenue declined by 4% to $137.8 million.
• Net loss widened to $64.9 million, mainly due to a $43.7 million goodwill impairment.

OPAL Fuels reported a solid year in 2024, achieving significant progress in operational and strategic objectives, including scaling rapidly by bringing three large landfill RNG projects online, increasing total annual design capacity to 11.4 million MMBtu, and more than tripling operating production capacity since becoming a public company in 2022.

• Revenue for the three months ended December 31, 2024, was $80.0 million, an 8% decrease compared to the same period last year.
• Net loss for the three months ended December 31, 2024, was $5.4 million, compared to a net income of $20.1 million in the comparable period last year.

GrowGeneration posted Q4 2024 revenue of $37.4 million, a decrease from the prior year due to store consolidations. The company's gross profit margin declined to 16.4% as a result of inventory rationalization efforts. Despite a net loss of $23.3 million, proprietary brand sales grew to 30.4% of total Cultivation and Gardening sales, supporting future margin improvement. The company remains focused on cost reductions and business transformation efforts.

• Revenue decreased 24.4% year-over-year to $37.4 million.
• Gross profit margin fell to 16.4% due to strategic inventory adjustments.

Altisource delivered a strong Q4 2024, with service revenue rising by 19% year-over-year to $38.4 million and adjusted EBITDA increasing significantly to $4.7 million. The company improved operational efficiency, strengthened its balance sheet through debt restructuring, and ended the quarter with $29.8 million in cash and cash equivalents.

• Service revenue increased by 19% YoY to $38.4 million, marking the highest quarterly service revenue since Q3 2021.
• Adjusted EBITDA grew to $4.7 million, the highest level since Q3 2020.

Portman Ridge posted Q4 2024 investment income of $14.4 million, reflecting a decrease from the prior year due to lower earnings from debt investments. The company's net investment income was $5.5 million, or $0.60 per share, down from $11.2 million in Q4 2023, largely due to the absence of a prior year non-recurring reimbursement. Net asset value per share decreased to $19.41, and the company continued share repurchases and announced a merger agreement with Logan Ridge.

• Total investment income declined to $14.4 million from $17.8 million in Q4 2023.
• Net investment income fell to $5.5 million ($0.60 per share), primarily due to prior-year non-recurring reimbursement.

CION Investment Corporation reported total investment income of $57.9 million in Q4 2024, with net investment income per share of $0.35. The company experienced a decrease in net asset value per share to $15.43 due to mark-to-market adjustments. Investments in senior secured loans remained the core of the portfolio, accounting for 86.1% of total investments.

• Total investment income reached $57.9 million, slightly lower than the prior quarter.
• Net investment income per share was $0.35, while EPS stood at $0.10.